Stockscreener 앱 받기
0.6329
7.87%
-0.0586
전일 마감가:
$0.6915
열려 있는:
$0.6725
하루 거래량:
1.68M
Relative Volume:
0.70
시가총액:
$112.32M
수익:
-
순이익/손실:
$-111.13M
주가수익비율:
-0.4795
EPS:
-1.32
순현금흐름:
$-91.53M
1주 성능:
+8.52%
1개월 성능:
+40.39%
6개월 성능:
-57.53%
1년 성능:
-78.33%
1일 변동 폭
$0.6258
$0.68
1주일 범위
$0.5372
$0.698
52주 변동 폭
$0.36
$4.06
Tenaya Therapeutics Inc Stock (TNYA) Company Profile
명칭
Tenaya Therapeutics Inc
전화
415-865-2066
주소
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO
TNYA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNYA
Tenaya Therapeutics Inc
|
0.6323 | 112.32M | 0 | -111.13M | -91.53M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.25 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
518.99 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
319.23 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
558.95 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
240.67 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Tenaya Therapeutics Inc Stock (TNYA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-10 | 개시 | William Blair | Outperform |
| 2023-11-30 | 개시 | Leerink Partners | Outperform |
| 2022-06-15 | 개시 | H.C. Wainwright | Buy |
Tenaya Therapeutics Inc 주식(TNYA)의 최신 뉴스
Brokerages Set Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Price Target at $6.25 - Defense World
Millennium Management LLC Sells 174,447 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (NASDAQ:TNYA) and Alpha Cognition (NASDAQ:ACOG) Critical Survey - Defense World
Squarepoint Ops LLC Decreases Stock Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Nuveen Asset Management LLC Buys 69,377 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Deutsche Bank AG Acquires 97,318 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Northern Trust Corp Grows Stock Holdings in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics Appoints New Directors at Annual Meeting - TipRanks
Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Receives $6.25 Average Target Price from Brokerages - Defense World
Price T Rowe Associates Inc. MD Sells 2,892,201 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock By Investing.com - Investing.com Nigeria
Tenaya Therapeutics chief medical officer sells $1,300 in stock - Investing.com Australia
Tenaya therapeutics SVP Higa Tomohiro sells $615 in stock - Investing.com
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - The Manila Times
Tenaya Therapeutics Awards Major Stock Options Package: 461K Shares for Strategic New Hires - Stock Titan
Greenlane Renewables Announces First Quarter 2025 Financial Results - The Globe and Mail
Barclays PLC Sells 184,837 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Tenaya Therapeutics (TNYA) to Showcase Key Research at ASGCT 2025 | TNYA Stock News - GuruFocus
Tenaya Therapeutics to Highlight Capsid Engineering, Gene Editing and Manufacturing Research at the ASGCT 28th Annual Meeting - The Manila Times
Tenaya Therapeutics to Present Five Abstracts on Innovative Heart Disease Gene Therapies at ASGCT 2025 Annual Meeting - Nasdaq
Tenaya Therapeutics to Highlight Capsid Engineering, Gene - GlobeNewswire
Hsbc Holdings PLC Purchases New Position in Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Equities Analysts Issue Forecasts for TNYA Q2 Earnings - Defense World
Tenaya Therapeutics’ (TNYA) Buy Rating Reiterated at Chardan Capital - Defense World
We're A Little Worried About Tenaya Therapeutics' (NASDAQ:TNYA) Cash Burn Rate - Yahoo Finance
Chardan Capital Maintains Buy Rating for Tenaya Therapeutics (TNYA) | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports Q1 2025 Financial Results - TipRanks
Tenaya (TNYA) Reports Promising Clinical Trial Developments and Financial Outlook | TNYA Stock News - GuruFocus
Tenaya Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
A Cautious Investment in the Drone Sector - The Globe and Mail
Geode Capital Management LLC Sells 27,419 Shares of Tenaya Therapeutics, Inc. (NASDAQ:TNYA) - Defense World
Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace
Why To Invest In Tenaya Therapeutics Inc (NASDAQ: TNYA) Stock? - Marketing Sentinel
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Buy on Tenaya Therapeutics stock - Investing.com Australia
TNYATenaya Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Tenaya reports progress in ARVC gene therapy study - Investing.com
Tenaya Therapeutics Presents Interim Data from RIDGE™ Natural History and Seroprevalence Study of Adults with PKP2-associated ARVC at Heart Rhythm 2025 - The Manila Times
Tenaya Therapeutics Presents Interim Data from RIDGE™ - GlobeNewswire
Major Breakthrough: 175-Patient ARVC Study Shows 93% Could Benefit from New Gene Therapy Treatment - Stock Titan
Strategy (MSTR) Buys Another $556 Million Worth of Bitcoin - The Globe and Mail
Tenaya Therapeutics faces Nasdaq delisting over share price By Investing.com - Investing.com India
Tenaya Therapeutics faces Nasdaq delisting over share price - Investing.com Australia
Tenaya Therapeutics Inc (TNYA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tenaya Therapeutics Inc 주식 (TNYA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tingley Whittemore | Chief Medical Officer |
May 16 '25 |
Sale |
0.44 |
2,937 |
1,300 |
171,856 |
| Ali Faraz | Chief Executive Officer |
May 16 '25 |
Sale |
0.44 |
3,189 |
1,412 |
317,325 |
| Higa Tomohiro | SVP, Finance |
Mar 10 '25 |
Sale |
0.54 |
2,482 |
1,336 |
99,690 |
| Tingley Whittemore | Chief Medical Officer |
Mar 10 '25 |
Sale |
0.54 |
7,398 |
3,983 |
174,793 |
| Ali Faraz | Chief Executive Officer |
Mar 10 '25 |
Sale |
0.54 |
9,741 |
5,245 |
320,514 |
1.37%
0.65%
자본화:
|
볼륨(24시간):